Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review

Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitrea...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2023-03, Vol.11 (3), p.e7011-n/a
Main Authors: Rashidi Alavijeh, Mehran, Mazaheri‐Tehrani, Sadegh, Saffari, Amir Sepehr, Fazel, Mohammadreza, Fazel, Farhad
Format: Article
Language:English
Subjects:
Apoptosis
Case Report
Case reports
Cell growth
Conflicts of interest
Consent
Editing
erythropoietin
Hypertension
Hypoxia
Ischemia
methanol
optic neuropathy
Steroids
toxicity
Writing
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3991-f753c566de8c6a33dcc943552996d0c4b8e9e66142d65ebae03f3bab0463c5a93
container_end_page n/a
container_issue 3
container_start_page e7011
container_title Clinical case reports
container_volume 11
creator Rashidi Alavijeh, Mehran
Mazaheri‐Tehrani, Sadegh
Saffari, Amir Sepehr
Fazel, Mohammadreza
Fazel, Farhad
description Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitreal erythropoietin in addition to corticosteroids. Despite usage of many drugs, methanol induced optic neuropathy (MION) is still poor prognosis. Combination of intravenous and intravitreal erythropoietin in addition to corticosteroid can be an opportunity to treat MION.
doi_str_mv 10.1002/ccr3.7011
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7b55a8dcf1044f249b386e30919a93bf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7b55a8dcf1044f249b386e30919a93bf</doaj_id><sourcerecordid>2791533709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3991-f753c566de8c6a33dcc943552996d0c4b8e9e66142d65ebae03f3bab0463c5a93</originalsourceid><addsrcrecordid>eNp1kkFr3DAQhU1paUKaQ_9AEfTSHjYZWZZs9VAIS5MuBAqlPQtZHu9qsSVXljfZY_955d00JIVeJDF6-niaeVn2lsIFBcgvjQnsogRKX2SnOXBYgITi5ZPzSXY-jlsAoFDmnMLr7ISJqmQg-Gn2e-Vi0Dt0fhrJ0KXFHgo2BtQdwbCPm-AHbzFaR1ofSK-dXmOPLhLfkh7jRjvfkejvrbFxT_wQrSEOp_RMx83-E7kiRo9IAg4-RKJdQ-pgsU2FncW7N9mrVncjnj_sZ9nP6y8_ll8Xt99uVsur24VhUtJFW3JmuBANVkZoxhpjZME4z6UUDZiirlCiELTIG8Gx1gisZbWuoRDpnZbsLFsduY3XWzUE2-uwV15bdSj4sFY6JOsdqrLmXFeNaSkURZsXsmaVQAaSygSq28T6fGQNU91jY3DuWfcM-vzG2Y1a-52Sskx-iwT48AAI_teEY1S9HQ12nXaYJqHysmKlTBMUSfr-H-nWT8GlViWVpJyxEubffTyqTPDjGLB9NENBzTlRc07UnJOkfffU_aPybyqS4PIouLMd7v9PUsvld3ZA_gH3pMnK</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791533709</pqid></control><display><type>article</type><title>Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Rashidi Alavijeh, Mehran ; Mazaheri‐Tehrani, Sadegh ; Saffari, Amir Sepehr ; Fazel, Mohammadreza ; Fazel, Farhad</creator><creatorcontrib>Rashidi Alavijeh, Mehran ; Mazaheri‐Tehrani, Sadegh ; Saffari, Amir Sepehr ; Fazel, Mohammadreza ; Fazel, Farhad</creatorcontrib><description>Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitreal erythropoietin in addition to corticosteroids. Despite usage of many drugs, methanol induced optic neuropathy (MION) is still poor prognosis. Combination of intravenous and intravitreal erythropoietin in addition to corticosteroid can be an opportunity to treat MION.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.7011</identifier><identifier>PMID: 36873065</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Apoptosis ; Case Report ; Case reports ; Cell growth ; Conflicts of interest ; Consent ; Editing ; erythropoietin ; Hypertension ; Hypoxia ; Ischemia ; methanol ; optic neuropathy ; Steroids ; toxicity ; Writing</subject><ispartof>Clinical case reports, 2023-03, Vol.11 (3), p.e7011-n/a</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2023 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3991-f753c566de8c6a33dcc943552996d0c4b8e9e66142d65ebae03f3bab0463c5a93</cites><orcidid>0000-0002-7199-5696</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2791533709/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2791533709?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36873065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rashidi Alavijeh, Mehran</creatorcontrib><creatorcontrib>Mazaheri‐Tehrani, Sadegh</creatorcontrib><creatorcontrib>Saffari, Amir Sepehr</creatorcontrib><creatorcontrib>Fazel, Mohammadreza</creatorcontrib><creatorcontrib>Fazel, Farhad</creatorcontrib><title>Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review</title><title>Clinical case reports</title><addtitle>Clin Case Rep</addtitle><description>Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitreal erythropoietin in addition to corticosteroids. Despite usage of many drugs, methanol induced optic neuropathy (MION) is still poor prognosis. Combination of intravenous and intravitreal erythropoietin in addition to corticosteroid can be an opportunity to treat MION.</description><subject>Apoptosis</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cell growth</subject><subject>Conflicts of interest</subject><subject>Consent</subject><subject>Editing</subject><subject>erythropoietin</subject><subject>Hypertension</subject><subject>Hypoxia</subject><subject>Ischemia</subject><subject>methanol</subject><subject>optic neuropathy</subject><subject>Steroids</subject><subject>toxicity</subject><subject>Writing</subject><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kkFr3DAQhU1paUKaQ_9AEfTSHjYZWZZs9VAIS5MuBAqlPQtZHu9qsSVXljfZY_955d00JIVeJDF6-niaeVn2lsIFBcgvjQnsogRKX2SnOXBYgITi5ZPzSXY-jlsAoFDmnMLr7ISJqmQg-Gn2e-Vi0Dt0fhrJ0KXFHgo2BtQdwbCPm-AHbzFaR1ofSK-dXmOPLhLfkh7jRjvfkejvrbFxT_wQrSEOp_RMx83-E7kiRo9IAg4-RKJdQ-pgsU2FncW7N9mrVncjnj_sZ9nP6y8_ll8Xt99uVsur24VhUtJFW3JmuBANVkZoxhpjZME4z6UUDZiirlCiELTIG8Gx1gisZbWuoRDpnZbsLFsduY3XWzUE2-uwV15bdSj4sFY6JOsdqrLmXFeNaSkURZsXsmaVQAaSygSq28T6fGQNU91jY3DuWfcM-vzG2Y1a-52Sskx-iwT48AAI_teEY1S9HQ12nXaYJqHysmKlTBMUSfr-H-nWT8GlViWVpJyxEubffTyqTPDjGLB9NENBzTlRc07UnJOkfffU_aPybyqS4PIouLMd7v9PUsvld3ZA_gH3pMnK</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Rashidi Alavijeh, Mehran</creator><creator>Mazaheri‐Tehrani, Sadegh</creator><creator>Saffari, Amir Sepehr</creator><creator>Fazel, Mohammadreza</creator><creator>Fazel, Farhad</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7199-5696</orcidid></search><sort><creationdate>202303</creationdate><title>Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review</title><author>Rashidi Alavijeh, Mehran ; Mazaheri‐Tehrani, Sadegh ; Saffari, Amir Sepehr ; Fazel, Mohammadreza ; Fazel, Farhad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3991-f753c566de8c6a33dcc943552996d0c4b8e9e66142d65ebae03f3bab0463c5a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Apoptosis</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cell growth</topic><topic>Conflicts of interest</topic><topic>Consent</topic><topic>Editing</topic><topic>erythropoietin</topic><topic>Hypertension</topic><topic>Hypoxia</topic><topic>Ischemia</topic><topic>methanol</topic><topic>optic neuropathy</topic><topic>Steroids</topic><topic>toxicity</topic><topic>Writing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rashidi Alavijeh, Mehran</creatorcontrib><creatorcontrib>Mazaheri‐Tehrani, Sadegh</creatorcontrib><creatorcontrib>Saffari, Amir Sepehr</creatorcontrib><creatorcontrib>Fazel, Mohammadreza</creatorcontrib><creatorcontrib>Fazel, Farhad</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rashidi Alavijeh, Mehran</au><au>Mazaheri‐Tehrani, Sadegh</au><au>Saffari, Amir Sepehr</au><au>Fazel, Mohammadreza</au><au>Fazel, Farhad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review</atitle><jtitle>Clinical case reports</jtitle><addtitle>Clin Case Rep</addtitle><date>2023-03</date><risdate>2023</risdate><volume>11</volume><issue>3</issue><spage>e7011</spage><epage>n/a</epage><pages>e7011-n/a</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitreal erythropoietin in addition to corticosteroids. Despite usage of many drugs, methanol induced optic neuropathy (MION) is still poor prognosis. Combination of intravenous and intravitreal erythropoietin in addition to corticosteroid can be an opportunity to treat MION.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36873065</pmid><doi>10.1002/ccr3.7011</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7199-5696</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-0904
ispartof Clinical case reports, 2023-03, Vol.11 (3), p.e7011-n/a
issn 2050-0904
2050-0904
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7b55a8dcf1044f249b386e30919a93bf
source Wiley-Blackwell Open Access Collection; Publicly Available Content Database; PubMed Central
subjects Apoptosis
Case Report
Case reports
Cell growth
Conflicts of interest
Consent
Editing
erythropoietin
Hypertension
Hypoxia
Ischemia
methanol
optic neuropathy
Steroids
toxicity
Writing
title Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A49%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20plus%20intravitreal%20erythropoietin%20for%20management%20of%20methanol%20toxicity%20optic%20neuropathy:%20A%20case%20report%20and%20brief%20review&rft.jtitle=Clinical%20case%20reports&rft.au=Rashidi%C2%A0Alavijeh,%20Mehran&rft.date=2023-03&rft.volume=11&rft.issue=3&rft.spage=e7011&rft.epage=n/a&rft.pages=e7011-n/a&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.7011&rft_dat=%3Cproquest_doaj_%3E2791533709%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3991-f753c566de8c6a33dcc943552996d0c4b8e9e66142d65ebae03f3bab0463c5a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791533709&rft_id=info:pmid/36873065&rfr_iscdi=true